Aditxt, Inc. ( ADTX) - Key Metrics
ADTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0.60 | -$790.51 | -$226.96 | -$227.48 |
| 2025Q4 | $0.01 | -$125.86 | -$247.51 | -$247.88 |
| 2025Q3 | $0.02 | -$548.78 | -$53.51 | -$53.51 |
| 2025Q2 | $0.05 | -$345.28 | -$113.47 | -$113.47 |
| 2025Q1 | $0.01 | -$81.15 | -$166.46 | -$166.46 |
ADTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -0.01 |
| 2025Q4 | 0% | -0.30 |
| 2025Q3 | 0% | -8.36 |
| 2025Q2 | 0% | -2263.93 |
| 2025Q1 | 0% | -3374.14 |
ADTX
Price: $0
52 week price:
Earnings Per Share: -1380.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 201000
Market Capitalization: 2.9 million